期刊
JOURNAL OF INFECTIOUS DISEASES
卷 190, 期 1, 页码 148-155出版社
OXFORD UNIV PRESS INC
DOI: 10.1086/420786
关键词
-
Background. Factors that determine the immunological response to highly active antiretroviral therapy (HAART) are poorly defined. Objective. Our aim was to investigate predictors of immunological failure after initial CD4(+) response. Methods. Data were from EuroSIDA, a prospective, international, observational human immunodeficiency virus (HIV) type 1 cohort. Results. Of 2347 patients with an increase in CD4(+) cell count greater than or equal to100 cells/muL within 6-12 months of the initiation of HAART, 550 (23%) subsequently experienced immunological failure (CD4(+) count less than or equal to the pre-HAART value). The incidence of failure was 11.6 incidences/100 person-years of follow-up (95% confidence interval [CI], 10.2-13.4) during the first 12 months and decreased significantly over time (P < .0001). Independent predictors of immunological failure were pre-HAART CD4(+) cell count (per 50% higher; relative hazard [RH], 2.05; 95% CI, 1.83-2.31; P < .0001), time-updated virus load (per 1 log(10) higher; RH, 1.77; 95% CI, 1.64-1.92; P < .0001), and HIV-1 risk behavior (for a global comparison of risk groups). Conclusion. The risk of immunological failure in patients with an immunological response to HAART diminishes with a longer time receiving treatment and is associated with pretreatment CD4(+) cell count, ongoing viral replication, and intravenous drug use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据